Gene · 1548
Papers4,152
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,152
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hydroxylated Tetramethoxyflavone Affects Intestinal Cell Permeability and Inhibits Cytochrome P450 Enzymes. | Molecules | 2024 | 38257234 | PubTator, text mining | PubMed |
| Resistance to Combined Anthracycline-Taxane Chemotherapy Is Associated with Altered Metabolism and Inflammation in Breast Carcinomas. | Int J Mol Sci | 2024 | 38256136 | PubTator, text mining | PubMed |
| A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment. | Biomolecules | 2024 | 38254699 | PubTator, text mining | PubMed |
| Cytotoxic Effects of Major and Emerging Mycotoxins on HepaRG Cells and Transcriptomic Response after Exposure of Spheroids to Enniatins B and B1. | Toxins (Basel) | 2024 | 38251270 | PubTator, text mining | PubMed |
| Nicotine is associated with smoking dependence and vascular inflammation through cotinine: A mediation analysis. | Tob Induc Dis | 2024 | 38250634 | PubTator, text mining | PubMed |
| Exploring Citrus sinensis Phytochemicals as Potential Inhibitors for Breast Cancer Genes BRCA1 and BRCA2 Using Pharmacophore Modeling, Molecular Docking, MD Simulations, and DFT Analysis. | ACS Omega | 2024 | 38250382 | PubTator, text mining | PubMed |
| Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies. | Cancer Epidemiol Biomarkers Prev | 2024 | 38180474 | PubTator, text mining | PubMed |
| Associating CYP2A6 structural variants with ovarian and lung cancer risk in the UK Biobank: replication and extension. | Eur J Hum Genet | 2024 | 38097766 | PubTator, text mining | PubMed |
| Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub-Saharan African Populations. | Clin Pharmacol Ther | 2024 | 38049200 | PubTator, text mining | PubMed |
| Relevance of pharmacogenetic analyses and therapeutic drug monitoring of antidepressants for an individualized treatment of peripartum psychopathology. | Int Clin Psychopharmacol | 2024 | 37982307 | PubTator, text mining | PubMed |
| CYP2A6 associates with respiratory disease risk and younger age of diagnosis: a phenome-wide association Mendelian Randomization study. | Hum Mol Genet | 2024 | 37802914 | PubTator, text mining | PubMed |
| Nicotine Metabolite Ratio Decreases After Switching Off Efavirenz-Based Therapy in People With HIV Who Smoke. | Clin Pharmacol Ther | 2024 | 37787039 | PubTator, text mining | PubMed |
| Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings. | Neural Regen Res | 2024 | 37488838 | PubTator, text mining | PubMed |
| A Comprehensive Study to Unleash the Putative Inhibitors of Serotype2 of Dengue Virus: Insights from an In Silico Structure-Based Drug Discovery. | Mol Biotechnol | 2024 | 36307631 | PubTator, text mining | PubMed |
| Insights into Pharmacological Activities of Nicotine and 6-Hydroxy-L-nicotine, a Bacterial Nicotine Derivative: A Systematic Review. | Biomolecules | 2023 | 38254623 | PubTator, text mining | PubMed |
| Oxidative Stress and Redox-Dependent Pathways in Cholangiocarcinoma. | Antioxidants (Basel) | 2023 | 38247453 | PubTator, text mining | PubMed |
| Advice for smokers in smoking cessation clinic: a review. | Afr Health Sci | 2023 | 38223627 | PubTator, text mining | PubMed |
| Gentiopicroside-An Insight into Its Pharmacological Significance and Future Perspectives. | Cells | 2023 | 38201274 | PubTator, text mining | PubMed |
| Vascularized liver-on-a-chip model to investigate nicotine-induced dysfunction. | Biomicrofluidics | 2023 | 38155919 | PubTator, text mining | PubMed |
| Simultaneous Prediction Method for Intestinal Absorption and Metabolism Using the Mini-Ussing Chamber System. | Pharmaceutics | 2023 | 38140073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1548/papers?page=7